Personalized medicine made the news recently when, on April 6, 2017, the FDA allowed the marketing of 23andMe’s genetic health risk tests for ten diseases or conditions.
This month’s post focuses on a case that arose out of a data breach, which led to a class action where the plaintiffs alleged the defendant owed a legal duty to keep their information safe and prevent system vulnerabilities.
Healthcare providers may affiliate with third parties to perform various services. Not surprisingly, when such a third party commits what is alleged to be a wrongful act of some sort, such as a misdiagnosis or mistreatment, the injured individual might attempt to hold the healthcare provider responsible.
This month’s Legal eSpeaking post discusses recent breaches and considers how they might give rise to class actions against the provider which suffered the breach.
As we near the end of January, I’d like to take the opportunity to look ahead and consider what the potential “hot topics” in health information management (HIM) might be for 2017.
This post discusses a federal agency that may be unfamiliar to HIM professionals, and how it regulates healthcare providers.